Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study
Gantenbein A, Agosti R, Gobbi C, Flügel D, Schankin C, Viceic D, Zecca C, Pohl H. Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study. Cephalalgia 2021; 41:1181-1186.
May 17, 2021
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study
May 17, 2021
Cephalalgia 2021; 41:1181-1186
Gantenbein Andreas R, Agosti Reto, Gobbi Claudio, Flügel Dominique, Schankin Christoph J, Viceic Dragana, Zecca Chiara, Pohl Heiko
more
